Bloudek LM, Stokes M, Buse DC, et al. Cost of healthcare for patients with migraine in five European countries: Results from the International burden of migraine study (IBMS). The Journal of Headache and Pain 2012; 13: 361-378.
Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013; 33: 629-808.
Lam DW and LeRoith D. Metabolic Syndrome. [Updated 19 May 2015]. In: Endotext [Internet] (De Groot LJ, Beck-Peccoz P, Chrousos G, et al.eds). MDText.com, South Dartmouth, MA, http://www.ncbi.nlm.nih.gov/books/NBK278936/ (2000).
Winsvold BS, Sandven I, Hagen K, et al. Migraine, headache and development of metabolic syndrome: An 11-year follow-up in the Nord-Trøndelag Health Study (HUNT). Pain 2013; 154: 1305-1311.
Sacco S, Kurth T,. Migraine and the risk for stroke and cardiovascular disease. Current Cardiology Reports 2014; 16: 524-524.
Bigal ME, Lipton RB, Biaondi DM, et al. Weight change and clinical markers of cardiovascular disease risk during preventive treatment of migraine. Cephalalgia 2009; 11: 1188-1196.
He Z, Dong L, Zhang Y, et al. Metabolic syndrome in female migraine patients is associated with medication overuse headache: A clinical-based study in China. European Journal of Neurology 2015; 22: 1228-1234.
Alkerwi A, Guillaume M, Zannad F, et al. Nutrition, environment and cardiovascular health (NESCAV): Protocol of an inter-regional cross-sectional study. BMC Public Health. Epub ahead of print 15 November 2010. DOI: 10.1186/1471-2458-10-698.
Streel S, Donneau AF, Hoge A, et al. Socioeconomic impact on the prevalence of cardiovascular risk factors in Wallonia, Belgium: A population-based study. BioMed Research International 2015; 2015: 1-10.
Streel S, Donneau AF, Dardenne N, et al. Validation of an extended French version of ID Migraine™ as a migraine-screening tool. Cephalalgia 2015; 35: 437-442.
Sauvageot N, Alkerwi A, Albert A, et al. Use of food frequency questionnaire to assess relationships between dietary habits and cardiovascular risk factors in NESCAV study: Validation with biomarkers. Nutrition Journal 2013; 12: 143.
World Health Organization. Diet, nutrition and the prevention of chronic diseases. Technical Report, Series no. 916. Geneva: WHO, 2003.
Alkerwi A, Donneau AF, Sauvageot N, et al. Dietary, behavioural and socio-economic determinants of the metabolic syndrome among adults in Luxembourg: Findings from the ORISCAV-LUX study. Public Health Nutrition 2012; 15: 849-859.
Hercberg S, Chat-Yung S, Chauliac M,. The French national nutrition and health program: 2001-2006-2010. International Journal of Public Health 2008; 53: 68-77.
Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-2752.
Streel S, Donneau AF, Hoge A, et al. One-year prevalence of migraine using a validated extended French version of the ID Migraine™: A Belgian population-based study. Revue Neurologique 2015; 171: 707-714.
Sachdev A and Marmura MJ. Metabolic syndrome and migraine. Frontiers in Neurology 2012; 3: 161.
Salmasi M, Amini L, Javanmard SH, et al. Metabolic syndrome in migraine headache: A case-control study. Journal of Research in Medical Sciences. The Official Journal of Isfahan University of Medical Sciences 2014; 19: 13-17.
Goulart AC, Santos IS, Lotufo PA, et al. Gender aspects of the relationship between migraine and cardiovascular risk factors: A cross-sectional evaluation in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Cephalalgia 2015; 35: 1103-1114.
Guldiken B, Guldiken S, Taskiran B, et al. Migraine in metabolic syndrome. The Neurologist 2009; 15: 55-58.
Bhoi SK, Kalita J, Misra UK,. Metabolic syndrome and insulin resistance in migraine. The Journal of Headache and Pain 2012; 13: 321-326.
Sacco S, Altobelli E, Ornello R, et al. Insulin resistance in migraineurs: Results from a case-control study. Cephalalgia 2014; 34: 349-356.
Gozke E, Unal M, Engin H, et al. An observational study on the association between migraines and tension type headaches in patients diagnosed with metabolic syndrome. ISRN Neurology. Epub ahead of print 18 April 2013. DOI:10.1155/2013/147065.
Voss JD, Scher AI,. Headache linked with incidence of metabolic syndrome: Comment on migraine, headache and development of metabolic syndrome: An 11-year follow-up in the HUNT study. Pain 2013; 154: 1163-1164.
Winsvold BS, Hagen K, Aamodt AH, et al. Headache, migraine and cardiovascular risk factors: The HUNT study. European Journal of Neurology 2011; 18: 504-511.
Ferrari MD, Klever RR, Terwindt GS, et al. Migraine pathophysiology: Lessons from mouse models and human genetics. Lancet Neurology 2015; 14: 65-80.
Malik R, Winsvold B, Auffenberg E, et al. The migraine-stroke connection: A genetic perspective. Cephalalgia 2016; 36: 658-668.
Bernecker C, Ragginer C, Fauler G, et al. Oxidative stress is associated with migraine and migraine-related metabolic risk in females. European Journal of Neurology 2011; 18: 1233-1239.
Neri M, Frustaci A, Milic M, et al. A meta-analysis of biomarkers related to oxidative stress and nitric oxide pathway in migraine. Cephalalgia 2015; 35: 931-937.
Borkum JM,. Migraine triggers and oxidative stress: A narrative review and synthesis. Headache 2015; 56: 12-35.
Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. The Journal of Clinical Investigation 2004; 114: 1752-1761.
Bansal M and Kaushal N. Introduction to oxidative stress. In: Bansal M and Kaushal N (eds) Oxidative stress: Metabolism and their modulation. New Delhi: Springer India, 2014, pp.1-18.
Rani V, Deep G, Singh RK, et al. Oxidative stress and metabolic disorders: Pathogenesis and therapeutic strategies. Life Sciences 2016. Epub ahead of print. DOI: 10.1155/2016/9137629.
